Related Experiment Video
Updated: Jan 23, 2026

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
Cardiovascular manifestations of myotonic dystrophy
1APHP, Cochin Hospital, Cardiology Department, Centre de Référence de Pathologie Neuromusculaire, Nord Est, Ile de France, Paris-Descartes, Sorbonne Paris Cité University, Cochin Hospital, 27 Rue du Faubourg Saint Jacques, 75679 Paris Cedex 14 Paris, France.
Insights
Sudden cardiac death is a significant risk for adults with myotonic dystrophy. Annual follow-ups and pacemakers can prevent fatal arrhythmias in high-risk patients.
Area of Science:
- Cardiology
- Neurology
- Genetics
Background:
- Myotonic dystrophy is the most common adult neuromuscular dystrophy.
- Patients face high rates of cardiac arrhythmias and mortality.
- Sudden cardiac death is a primary concern.
Purpose of the Study:
- To outline strategies for preventing sudden cardiac death in myotonic dystrophy patients.
- To emphasize the importance of regular cardiac monitoring.
Main Methods:
- Annual cardiovascular follow-up.
- Electrocardiogram (ECG) and electrophysiological studies (EPS) for conduction defects.
- Prophylactic permanent pacemaker implantation.
- Implantable cardiac defibrillator (ICD) consideration for ventricular tachyarrhythmia.
Main Results:
- Conduction defects and infrahisian blocks necessitate pacing.
- Ventricular tachyarrhythmia may require ICD therapy.
- Proactive management significantly reduces cardiovascular mortality risk.
Conclusions:
- Sudden death prevention is paramount in myotonic dystrophy care.
- Regular screening and timely interventions like pacing and ICDs are crucial.
- Effective management strategies improve outcomes for these patients.
Abstract:
Patients with myotonic dystrophy, the most common neuromuscular dystrophy in adults, have a high prevalence of arrhythmic complications with increased cardiovascular mortality and high risk for sudden death. Sudden death prevention is central and relies on annual follow-up and prophylactic permanent pacing in patients with conduction defects on electrocardiogram and/or infrahisian blocks on electrophysiological study. Implantable cardiac defibrillator therapy may be indicated in patients with ventricular tachyarrhythmia.
Related Concept Videos
Overview of the Cardiovascular System
Heart
The heart is the central pump of the cardiovascular system that circulates blood throughout the body. It comprises two atria receiving the blood and two ventricles pumping blood out of the heart. Their rhythmic contractions, called heartbeats, ensure that blood flow remains continuous.
Blood Vessels
Blood...
Satellite Stem Cells and Muscular Dystrophy
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Acute Pancreatitis II: Clinical Manifestations and Management
Angina III: Clinical Manifestations and Assessment
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

